AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Senti Bio Extends Cash Runway to 2026 with Additional $11.5 Million Financing
ByAinvest
Monday, Jan 6, 2025 9:02 am ET1min read
Senti Bio has raised an additional $11.5 million in financing, bringing the total raised in the round to $47.6 million. The additional funding will extend the company's cash runway guidance into 2026 and will be used to fund the development of its SENTI-202 program and manufacturing ramp-up, as well as other research and development activities. The financing was led by Celadon Partners and included participation from New Enterprise Associates (NEA), Leaps by Bayer, and other institutional and accredited investors.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet